ClinicalTrials.gg
RecruitingNCT07138911Updated Feb 25, 2026

Effect of Home-based Exercise Plan Mediated by Use of Digital Health App on Kinesiophobia and Functional Capacity

An interventional study of Intervention group and Control group in Myocardial Infarction, Kinesiophobia and Sedentary Behavior, sponsored by Riphah International University. Recruiting at 1 site in Pakistan. Open to participants aged 30 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-02-25.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Feb 2026, 8 months ago, but the record still lists the study as recruiting.
  • Started Aug 2025; still recruiting 1 year 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
88
Allocation
Non-randomized
Ages
30 Years to 55 Years
Sex
All
01

Study summary

To evaluate the effect of home-based exercise plan mediated by a digital health application on kinesiophobia and functional capacity in sedentary post myocardial infarction patients. Evidence suggest that digital health application significantly improve physical activity level in patient following cardiac event by providing personalized exercise plan, real time feed back, progress tracking and motivational features which enhanced adherence and engagement in rehabilitation program. This study could offer a viable le solution for overcoming barrier to rehabilitation particularly for those unable to access traditional clinic-based program

Read the detailed description

Mobile health (m health) strategies to increase adherence to physical activity is a promising approach. Mobile technology has become more integrated with health care and use of mobile health apps has become feasible for even the most novice users. Mobile health app can be effective adjuncts for the management of chronic condition and have a positive impact on long term behavior. The mobile health app promote the physical activity maintenance after cardiac rehabilitation. Recently, researchers have stated that mobile health intervention promoting the physical activity in the patient of cardiovascular disease. Mobile health intervention promote physical activity and daily step count after completing cardiac rehab.

02

Conditions studied

  • Myocardial Infarction
  • Kinesiophobia
  • Sedentary Behavior

Keywords

  • Digital health app
  • Functional capacity
  • Kinesiophobia
  • Myocardial Infarction
  • Sedentary
03

In context

Myocardial Infarction

2,270 studies on the registry are indexed under Myocardial Infarction; 371 are open to participants now.

This study's planned enrollment of 88 is below the median of 150 across 1,314 interventional studies indexed under Myocardial Infarction.

Browse Myocardial Infarction studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,193 studies on the registry; 650 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 3 months post myocardial infarction patient
  • Sitting hours >8
  • IPAQ \< 600 Mets minutes

Exclusion criteria

Exclusion Criteria:

  • Unstable Angina
  • Recurrent Myocardial infarction
  • Recent surgery or Procedure
  • Heart failure, Arrhythmia
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
88 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Home based exercise plan mediated by use of mobile health app

    Other: Intervention group

  • Active comparator
    Control Group

    Home based exercise plan

    Other: Control group

Interventions

  • OtherIntervention group

    Walking at home for 15-30 minutes 3 times per day for 4 weeks. Activity plan is calendar on mobile health app. Mobile placed in pocket or bag before starting walk and mark activity on calendar.

  • OtherControl group

    Walking at home for 15-30 minutes 3 times per day for 4 weeks. Manual record of walking and date.

06

What researchers measure

Primary outcomes

  1. Kinesiophobia

    Changes from baseline to 4 weeks after intervention, measured through the TSK-SV Heart specifically focuses on assessing Kinesiophobia in the context of cardiac conditions or symptoms. It include questions related to fear of engaging in physical activity due to concerns about cardiac events (such as heart palpitations, chest pain, or shortness of breath) during exercise or daily activities. The 17 item TSK total scores range from 17 to 68 where the lowest 17 means no or negligible Kinesiophobia, and the higher scores indicate an increasing degree of Kinesiophobia.

    Time frame: 4 Weeks

  2. Functional Capacity

    Changes from baseline to 4 weeks after intervention, measured through six minute walk test which is a sub-maximal exercise test used to assess functional capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.

    Time frame: 4 Weeks

07

Study locations

1 of 1 sites recruiting
  • Polyclinic Hospital
    Islamabad, Federal 45300, Pakistan
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2025 (actual). Primary completion is estimated for Feb 2026, 6 months after the start.

Of 321 non-industry interventional studies with no phase under Myocardial Infarction, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 58. This study's planned 6 months is below that.

Counting every sponsor, half of 354 studies reached it within 34 months; a quarter within 15 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 18, 2025
First posted
Aug 24, 2025
StartActual
Aug 13, 2025
Primary completionEst.
Feb 20, 2026
CompletionEst.
Feb 25, 2026
Last update
Feb 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07138911
Responsible party
Sponsor
First posted
Aug 24, 2025
Start date
Aug 13, 2025
Primary completion
Feb 20, 2026 (estimated)
Completion
Feb 25, 2026 (estimated)
Last update
Feb 25, 2026

Study contacts

Mehwish Waseem, MS-CPPT PhD*
Contact
mehwish.waseem@riphah.edu.pk
0331-5309015
Mehwish Waseem, MS-CPPT PhD*
principal investigator · Riphah International University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion